A Phase II, randomised, multi-centric, multi-national clinical trial to evaluate the efficacy, tolerability, and safety of a fixed dose combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) for adolescent girls and young adult women (AYAs) with polycystic ovary syndrome (PCOS).
Active, not recruitingCTIS2024-518527-29-00
Fundacio Sant Joan De DeuPolycystic ovary syndrome (PCOS)
Start: 2022-05-24Target: 316Updated: 2025-11-13